CD8A and neoplasm: The enhanced immune response was evidenced by increased CD8+ cytotoxic T cells and reduced Tregs, along with higher levels of mature dendritic cells (DCs), leading to a robust antitumor immune response and preventing tumor recurrence during the rechallenge test.